Matrix Metalloproteinases as Novel Biomarker S and Potential Therapeutic Targets in Human Cancer

Journal of Clinical Oncology - United States
doi 10.1200/jco.2009.23.5556
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated With Varicose Veins

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2013English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

Acute Actions and Novel Targets of Matrix Metalloproteinases in the Heart and Vasculature

British Journal of Pharmacology
Pharmacology
2007English

Editorial: Matricellular Receptors as Potential Targets in Anti-Cancer Therapeutic Strategies

Frontiers in Pharmacology
Pharmacology
2016English

Matrix Metalloproteinases in Cancer

Essays in Biochemistry
BiochemistryMolecular Biology
2002English

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

GPCRs as Potential Therapeutic Targets in Preeclampsia

Drug Discovery Today: Disease Models
Drug DiscoveryMolecular Medicine
2012English

Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma

International Journal of Hematology-Oncology and Stem Cell Research
OncologyTransplantationHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy